Increasing evidence demonstrates that this histone methyltransferase plays a pivotal role in neuroinflammation-associated neurological diseases through modification of specific genes [10,11], indicating epigenetic regulation as a potential targeting approach to control neuroinflammation [12]. Here, PRDM9 is linked to nervous system disorder.